Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

Uyttenhove, Catherine, Pilotte, Luc, Théate, Ivan, Stroobant, Vincent, Colau, Didier, Parmentier, Nicolas, Boon, Thierry, Van den Eynde, Benoît J·2003·Nature Medicine

DOI 10.1038/nm934

Cited by (1,003)

Items 601–700 of 1,003

Phenotypic diversity of T cells in human primary and metastatic brain tumors revealed by multiomic interrogation
Vladimir Wischnewski, Roeltje R. Maas, Paola Guerrero Aruffo, Klara Soukup, Giovanni Galletti, Mara Kornete, Sabine Galland, Nadine Fournier, Johanna Lilja, Pratyaksha Wirapati et al. · 2023 · Nature Cancer
Towards a Genetic Definition of Cancer-Associated Inflammation
George C. Prendergast, Richard A. Metz, Alexander J. Muller · 2010 · American Journal Of Pathology
Imaging Correlates of Differential Expression of Indoleamine 2,3-Dioxygenase in Human Brain Tumors
Carlos Eduardo Alves Batista, Csaba Juhász, Otto Muzik, William J. Kupsky, Geoffrey R. Barger, Harry T. Chugani, Sandeep Mittal, Sandeep Sood, Pulak K. Chakraborty, Diane C. Chugani · 2009 · Molecular Imaging and Biology
Rational combinations of immunotherapeutics that target discrete pathways
Stefani Spranger, Thomas Frank Gajewski · 2013 · Journal for ImmunoTherapy of Cancer
Prognostic value of tumor infiltrating lymphocyte subsets in breast cancer depends on hormone receptor status
Yul Ri Chung, Hyun Jeong Kim, Min Hye Jang, So Yeon Park · 2016 · Breast Cancer Research and Treatment
Engineering Chimeric Antigen Receptor T-Cells for Racing in Solid Tumors: Don’t Forget the Fuel
Melita B. Irving, Romain Vuillefroy de Silly, Kirsten B. J. Scholten, Nahzli Dilek, George Coukos · 2017 · Frontiers in Immunology
Cancer vaccines 2004 opening address: the molecular and cellular basis of cancer immunosurveillance and immunoediting.
Krassimira O. Todorova, Irena Ignatova, Stoyan Tchakarov, Iskra Altankova, Serguei Zoubak, Stanimir Kyurkchiev, Milcho S. Mincheff · 2005 · PubMed
Research Progress of Indoleamine 2,3-Dioxygenase Inhibitors
Tianze Jiang, Yingying Sun, Zhichao Yin, Sen Feng, Li‐Ping Sun, Zhiyu Li · 2015 · Future Medicinal Chemistry
The Dynamic Genome and Transcriptome of the Human Fungal Pathogen Blastomyces and Close Relative Emmonsia
José Fernando Muñoz, Gregory M. Gauthier, Christopher A. Desjardins, Juan Esteban Gallo, Jason W. Holder, Thomas D. Sullivan, Amber J. Marty, John Cherrington Carmen, Zehua Chen, Li Ding et al. · 2015 · PLoS Genetics
TCR-engineered T cells to treat tumors: Seeing but not touching?
Reno Debets, Emmanuel Donnadieu, Salem Chouaı̈b, George Coukos · 2016 · Seminars in Immunology
Preventing Lck Activation in CAR T Cells Confers Treg Resistance but Requires 4-1BB Signaling for Them to Persist and Treat Solid Tumors in Nonlymphodepleted Hosts
Carter M. Suryadevara, Rupen R. Desai, Samuel Harrison Farber, Bryan D. Choi, Adam M. Swartz, Steven H. Shen, Patrick C. Gedeon, David J. Snyder, James E. Herndon, Patrick N Healy et al. · 2018 · Clinical Cancer Research
Indoleamine and tryptophan 2,3-dioxygenases as important future therapeutic targets
Ana Dolšak, Stanislav Gobec, Matej Sova · 2020 · Pharmacology & Therapeutics
The role of metabolic reprogramming of tumor-associated macrophages in shaping the immunosuppressive tumor microenvironment
Lunxu Li, Yu Tian · 2023 · Biomedicine & Pharmacotherapy
Nanotechnology Reprogramming Metabolism for Enhanced Tumor Immunotherapy
Yangkai Zhou, Jing Tang Yuan, Ke Xu, Shilin Li, Ying Liu · 2024 · ACS Nano
In vitro testing for anti-inflammatory properties of compounds employing peripheral blood mononuclear cells freshly isolated from healthy donors
M. Jenny, Martin Klieber, Daniela Zaknun, Sebastian Schroecksnadel, Katharina Kurz, Maximilian Ledochowski, Harald Schennach, Dietmar Fuchs · 2010 · Inflammation Research
Suppressive Influences in the Immune Response to Cancer
Vincenzo Bronte, Simone Mocellin M. D · 2008 · Journal of Immunotherapy
Molecular mechanisms involved in the adaptation to amino acid limitation in mammals
Cédric Chaveroux, Sarah Lambert-Langlais, Yoan Chérasse, Julien Avérous, Laurent Parry, Valérie Carraro, Céline Jousse, Anne‐Catherine Maurin, Alain Bruhat, Pierre Fafournoux · 2010 · Biochimie
Effector-phase tolerance: another mechanism of how cancer escapes antitumor immune response
Alan B. Frey, Ngozi R. Monu · 2006 · Journal of Leukocyte Biology
Indoleamine-2,3-dioxygenase, an immunosuppressive enzyme that inhibits natural killer cell function, as a useful target for ovarian cancer therapy
DONGDONG WANG, Yasushi Saga, Hiroaki Mizukami, Naoto Sato, HIROAKI NONAKA, Hiroyuki Fujiwara, Yuji Takei, 静生町田, Osamu Takikawa, Keiya Ozawa et al. · 2011 · International Journal of Oncology
Hypoxia-inducible factor-2 is essential in activating the COX2/mPGES-1/PGE2 signaling axis in colon cancer
Xiang Xue, Yatrik Madhukar Shah · 2012 · Carcinogenesis
Metabolism in cancer metastasis: bioenergetics, biosynthesis, and beyond
Shao Thing Teoh, Sophia Y. Lunt · 2017 · WIREs Systems Biology and Medicine
The Human T Cell Response to Melanoma Antigens
Pedro J. Romero, Jean‐Charles Cerottini, Daniel E. Speiser · 2006 · Advances in immunology
Next generation immune-checkpoints for cancer therapy
Chiara Donini, Lorenzo D’Ambrosio, Giovanni Grignani, Massimo Aglietta, Dario Sangiolo · 2018 · Journal of Thoracic Disease
Metabolic regulation of the cancer-immunity cycle
Luis F. Somarribas Patterson, Santosha Adipudi Vardhana · 2021 · Trends in Immunology
Characterization and evolution of vertebrate indoleamine 2, 3-dioxygenases
Hajime Julie Yuasa, Helen J. Ball, Yuen Fern Ho, Christopher Austin, Camilla M. Whittington, Katherine Belov, Ghassan J. Maghzal, Lars Sommer Jermiin, Nicholas Henry Hunt · 2009 · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology
High expression of indoleamine 2,3-dioxygenase gene in prostate cancer
Chantal Feder‐Mengus, Stephen Frederic Wyler, Tvrtko Hudolin, Robin Ruszat, Lukas Bubendorf, Alberto Chiarugi, Maria Gloria Pittelli, William P. Weber, Alexander Bachmann, Thomas C. Gasser et al. · 2008 · European Journal of Cancer
A Spliced Antigenic Peptide Comprising a Single Spliced Amino Acid Is Produced in the Proteasome by Reverse Splicing of a Longer Peptide Fragment followed by Trimming
Alexandre Michaux, Pierre Larrieu, Vincent Stroobant, Jean‐François Fonteneau, Francine Jotereau, Benoit J. Van den Eynde, Agnès Moreau‐Aubry, Nathalie Vigneron · 2014 · The Journal of Immunology
T Lymphocytes Restrain Spontaneous Metastases in Permanent Dormancy
Irene Romero, Cristina Garrido, Ignacio Algarra, Antonia Collado, Federico Garrido, Angel Miguel Garcia-Lora · 2014 · Cancer Research
Serum Tryptophan and Kynurenine Concentrations as Parameters for Indoleamine 2,3-Dioxygenase Activity in Patients With Endometrial,Ovarian, and Vulvar Cancer
Renske A. de Jong, Hans W. Nijman, H. Marike Boezen, Marcel Volmer, Klaske A. ten Hoor, Jasper Krijnen, Ate G.J. van der Zee, Harry Hollema, Ido P. Kema · 2011 · International Journal of Gynecological Cancer
The pancreatic cancer microenvironment: A true double agent
Laleh Golkar Melstrom, Marcela d'Alincourt Salazar, Don J. Diamond · 2017 · Journal of Surgical Oncology
Dual-Blockade Immune Checkpoint for Breast Cancer Treatment Based on a Tumor-Penetrating Peptide Assembling Nanoparticle
Guorui Li, Yuan Gao, Chunai Gong, Zhimin Han, Lei Qiang, Zongguang Tai, Jing Tian, Shen Gao · 2019 · ACS Applied Materials & Interfaces
Activatable Semiconducting Polymer Pro‐nanomodulators for Deep‐Tissue Sono‐immunotherapy of Orthotopic Pancreatic Cancer
Jingchao Li, Ningyue Yu, Dong Mei Cui, Jiaguo Huang, Yu Luo, Kanyi Pu · 2023 · Angewandte Chemie International Edition
T cell dysfunction in cancer: Role of myeloid cells and tumor cells regulating amino acid availability and oxidative stress
Paulo C. Rodrı́guez, Augusto C. Ochoa · 2005 · Seminars in Cancer Biology
Structure–activity relationship and enzyme kinetic studies on 4-aryl-1H-1,2,3-triazoles as indoleamine 2,3-dioxygenase (IDO) inhibitors
Qiang Huang, Maofa Zheng, Shuangshuang Yang, Chunxiang Kuang, Cun-Jing Yu, Qing Yang · 2011 · European Journal of Medicinal Chemistry
Tryptophan degradation in women with breast cancer: a pilot study
Debra Lyon, Jeanne M. Walter, Angela Renee Starkweather, Christine M. Schubert, Nancy L. McCain · 2011 · BMC Research Notes
Uveal melanoma expression of indoleamine 2,3-deoxygenase: Establishment of an immune privileged environment by tryptophan depletion
Peter W. Chen, Jessamee Mellon, Elizabeth S. Mayhew, Shixuan Wang, Yu Guang He, Nick Hogan, Jérry Y. Niederkorn · 2007 · Experimental Eye Research
Mechanisms of Local Immunoresistance in Glioma
Emilia Albesiano, James E. Han, Michael K. Lim · 2009 · Neurosurgery Clinics of North America
Endotoxin-Induced Tryptophan Degradation along the Kynurenine Pathway: The Role of Indolamine 2,3-Dioxygenase and Aryl Hydrocarbon Receptor-Mediated Immunosuppressive Effects in Endotoxin Tolerance and Cancer and Its Implications for Immunoparalysis
Elisa Wirthgen, Andreas Hoeflich · 2015 · Journal of Amino Acids
Low-Intensity Focused Ultrasound Induces Reversal of Tumor-Induced T Cell Tolerance and Prevents Immune Escape
Sanmay Bandyopadhyay, Thomas J. Quinn, Lisa Scandiuzzi, Indranil Basu, Ari Partanen, Wolfgang A. Tomé, Fernando Macián, Chandan Guha · 2016 · The Journal of Immunology
The mechanisms tumor cells utilize to evade the host's immune system
Nyanbol Kuol, Lily Stojanovska, Kulmira Nurgali, Vasso Apostolopoulos · 2017 · Maturitas
Inhibition of Tryptophan-Dioxygenase Activity Increases the Antitumor Efficacy of Immune Checkpoint Inhibitors
Florence Schramme, Stefano Crosignani, Kim Frederix, Delia Hoffmann, Luc Pilotte, Vincent Stroobant, Julie Preillon, Grégory Driessens, Benoit J. Van den Eynde · 2019 · Cancer Immunology Research
Role of tryptophan metabolism in cancers and therapeutic implications
Xiaohan Liu, Xiao‐Yue Zhai · 2021 · Biochimie
Selective Treg reconstitution during lymphopenia normalizes DC costimulation and prevents graft-versus-host disease
Holly A. Bolton, Erhua Zhu, Alexandra M. Terry, Thomas V. Guy, Woon‐Puay Koh, Sioh‐Yang Tan, Carl Andrew Power, Patrick Bertolino, Katharina Lahl, Tim D. Sparwasser et al. · 2015 · Journal of Clinical Investigation
Detailed analysis and follow-up studies of a high-throughput screening for indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors
Ute F. Röhrig, Somi Reddy Majjigapu, Marc Chambon, Sylvian Bron, Luc Pilotte, Didier Colau, Benoit J. Van den Eynde, Gerardo Turcatti, Pierre Vogel, Vincent Zoete et al. · 2014 · European Journal of Medicinal Chemistry
CD40 ligation reverses T cell tolerance in acute myeloid leukemia
Long Zhang, Xiufen Chen, Xiao Liu, Douglas E. Kline, Ryan M. Teague, Thomas F. Gajewski, Justin Paul Kline · 2013 · Journal of Clinical Investigation
Indoleamine 2,3-dioxygenase expression predicts impaired survival of invasive cervical cancer patients treated with radical hysterectomy
Tomoko Inaba, Kazuhiko Ino, Hiroaki Kajiyama, Kiyosumi Shibata, Eiko Yamamoto, Shinji Kondo, Tomokazu Umezu, Akihiro Nawa, Osamu Takikawa, Fumitaka Kikkawa · 2010 · Gynecologic Oncology
IDO1 inhibition potentiates vaccine-induced immunity against pancreatic adenocarcinoma
Alex B. Blair, Jennifer Kleponis, Dwayne L. Thomas, Stephen T. Muth, Adrian Gerard Murphy, Victoria Kim, Lei Zheng · 2019 · Journal of Clinical Investigation
The effects of age and systemic metabolism on anti-tumor T cell responses
Drijvers, Jefte M, Sharpe, Arlene H, Haigis, Marcia C · 2020 · eLife
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) consensus statements on pre-invasive vulvar lesions
Mario Preti, Elmar Armin Joura, Pedro Vieira‐Baptista, Marc van Beurden, Federica Bevilacqua, Maaike C.G. Bleeker, Jacob Bornstein, Xavier Carcopino, Cyrus Chargari, Margaret Eleanor Cruickshank et al. · 2022 · International Journal of Gynecological Cancer
Cancer immunotherapy takes a multi-faceted approach to kick the immune system into gear.
Peniel Dimberu, Ralf M. Leonhardt · 2011 · Europe PMC (PubMed Central)
Quantitative and spatial differences in the expression of tryptophan-metabolizing enzymes in mouse epididymis
Aurore Britan, Violette Maffre, Shigenobu Toné, Joël R. Drevet · 2006 · Cell and Tissue Research
Indoleamine 2,3‐dioxygenase promotes peritoneal metastasis of ovarian cancer by inducing an immunosuppressive environment
優子谷崎, Aya Kobayashi, Saori Toujima, Michihisa Shiro, Mika Mizoguchi, Yasushi Mabuchi, Shigetaka Yagi, Sawako Minami, Osamu Takikawa, Kazuhiko Ino · 2014 · Cancer Science
Interleukins 1α and 1β secreted by some melanoma cell lines strongly reduce expression of MITF‐M and melanocyte differentiation antigens
Olga Kholmanskikh, Nicolas van Baren, Francis Brasseur, Sabrina Ottaviani, Julie Vanacker, Nathalie Arts, Pierre van der Bruggen, Pierre G. Coulie, Etienne De Plaen · 2010 · International Journal of Cancer
Deficiency of Indoleamine 2,3-Dioxygenase Enhances Commensal-Induced Antibody Responses and Protects against Citrobacter rodentium -Induced Colitis
Lynne Harrington, Chittur V. Srikanth, Reuben Antony, Sue Rhee, Andrew L. Mellor, Hai Ning Shi, Bobby J. Cherayil · 2008 · Infection and Immunity
Restoring Natural Killer Cell Immunity against Multiple Myeloma in the Era of New Drugs
Gianfranco Pittari, Luca Vago, Moreno Benedetto Festuccia, Chiara Bonini, Deena Mudawi, Luisa Giaccone, Benedetto Bruno · 2017 · Frontiers in Immunology
Interferons: Reprogramming the Metabolic Network against Viral Infection
Kavita Raniga, Chen Liang · 2018 · Viruses
The paradox of T cell?mediated antitumor immunity in spite of poor clinical outcome in human melanoma
Andrea Anichini, Claudia Vegetti, Roberta Mortarini · 2004 · Cancer Immunology Immunotherapy
Immune Checkpoint Blockade in Cancer Treatment: A Double-Edged Sword Cross-Targeting the Host as an “Innocent Bystander”
Lucia Gelao, Carmen Criscitiello, Angela Espósito, Aron Goldhirsch, Giuseppe Curigliano · 2014 · Toxins
Immune Mechanisms in Myelodysplastic Syndrome
Andreas Birkedal Glenthøj, Andreas Due Ørskov, Jakob Hansen, Sine Reker Hadrup, Casey Lee O'Connell, Kirsten Grønbæk · 2016 · International Journal of Molecular Sciences
Effects of microenvironment in osteosarcoma on chemoresistance and the promise of immunotherapy as an osteosarcoma therapeutic modality
Lei Yu, Jian Zhang, Yunfeng Li · 2022 · Frontiers in Immunology
Nitration and Inactivation of IDO by Peroxynitrite
Hidetsugu Fujigaki, Kuniaki Saito, Felix Lin, Suwako Fujigaki, Kanako Takahashi, Brian M. Martin, Cai Y. Chen, Junichi Masuda, Jeffrey A. Kowalak, Osamu Takikawa et al. · 2006 · The Journal of Immunology
Prognostic value of indoleamine 2,3-dioxygenase expression in high grade osteosarcoma
Hiroshi Urakawa, Yoshihiro Nishida, Hiroatsu Nakashima, Yoshie Shimoyama, Shigeo Nakamura, Naoki Ishiguro · 2009 · Clinical & Experimental Metastasis
Peritumoral indoleamine 2,3‐dioxygenase expression in melanoma: an early marker of resistance to immune control?
Inès Chevolet, Reinhart Speeckaert, Marc Haspeslagh, Bart Neyns, Vibeke Krüse, Max S. Schreuer, Mireille Van Gele, Nanja van Geel, Liève Brochez · 2014 · British Journal of Dermatology
The Immune System Strikes Back: Cellular Immune Responses against Indoleamine 2,3-dioxygenase
Rikke Bæk Sørensen, Linda Berge-Hansen, Niels Junker, Christina Aaen Hansen, Sine Reker Hadrup, Ton N. Schumacher, Inge Marie Svane, Jürgen Christian Becker, Per thor Straten, Mads Hald Andersen · 2009 · PLoS ONE
Amino acid profile index for early detection of endometrial cancer: verification as a novel diagnostic marker
Yutaka IHATA, Etsuko Miyagi, Reiko Numazaki, Takahiko Muramatsu, Akira Imaizumi, Hiroshi Yamamoto, Minoru Yamakado, Naoyuki Okamoto, Fumiki Hirahara · 2013 · International Journal of Clinical Oncology
BAR the door: Cancer suppression by amphiphysin-like genes
Prendergast, George C., Muller, Alexander J., Ramalingam, Arivudanambi, Chang, Mee Young · 2009 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Reverting Immune Suppression to Enhance Cancer Immunotherapy
Bella Samia Guerrouahen, Cristina Maccalli, Chiara Cugno, Sergio Rutella, Emmanuel T. Akporiaye · 2020 · Frontiers in Oncology
Indoleamine 2,3-dioxygenase activity and l-tryptophan transport in human breast cancer cells
M T Travers, Iain F Gow, MICHAEL C. BARBER, Jean Thomson, DAVID B. SHENNAN · 2003 · Biochimica et Biophysica Acta (BBA) - Biomembranes
Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma
Giuseppina Bonanno, Andrea Mariotti, Annabella Procoli, Valentina Folgiero, Daniela Natale, Luca De Rosa, Ignazio Majolino, Linda Novarese, Alberto Rocci, Manuela Gambella et al. · 2012 · Journal of Translational Medicine
Immune checkpoint blockade and its combination therapy with small-molecule inhibitors for cancer treatment
Wang, Manni, Liu, Yu, Cheng, Yuan, Wei, Yuquan, Wei, Xiawei · 2019 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Noncoding RNAs: the shot callers in tumor immune escape
Lei Liu, Qin Wang, Zhilin Qiu, Yujuan Kang, Jiena Liu, Shipeng Ning, Yanling Yin, Da Pang, Shouping Xu · 2020 · Signal Transduction and Targeted Therapy
The Role of Indoleamine 2, 3-Dioxygenase 1 in Regulating Tumor Microenvironment
Xinting Huang, Feng Zhang, Xiaobo Wang, Ke Liu · 2022 · Cancers
Indoleamine 2,3-dioxygenase as a new target for malignant glioma therapy
Takeshi Miyazaki, Kouzo Moritake, Kazuo Yamada, Nobumasa Hara, Harumi Osago, Tomoko Shibata, Yasuhiko Akiyama, Mikako Tsuchiya · 2009 · Journal of neurosurgery
The missing link between indoleamine 2,3‐dioxygenase mediated antibacterial and immunoregulatory effects
Anika Müller, Kathrin Heseler, Silvia K. Schmidt, Katrin Spekker, Colin R. MacKenzie, Walter Däubener · 2008 · Journal of Cellular and Molecular Medicine
The paradoxical patterns of expression of indoleamine 2,3-dioxygenase in colon cancer
Yan-fang Gao, Ruiqing Peng, Jiang Li, Ya Ding, Xing Zhang, Xiaojun Wu, Zhizhong Pan, De-Sen Wan, Yi-Xin Zeng, Xiaoshi Zhang · 2009 · Journal of Translational Medicine
A high-affinity, tryptophan-selective amino acid transport system in human macrophages
Robert L. Seymour, Vadivel Ganapathy, Andrew L. Mellor, David H. Munn · 2006 · Journal of Leukocyte Biology
Safety and Antitumor Activity of α-PD-L1 Antibody as Monotherapy or in Combination with α-TIM-3 Antibody in Patients with Microsatellite Instability–High/Mismatch Repair–Deficient Tumors
Hollebecque, Antoine, Chung, Hyun C., de Miguel, Maria J., Italiano, Antoine, Machiels, Jean-Pascal, Lin, Chia-Chi, Dhani, Neesha C., Peeters, Marc, Moreno, Victor, Su, Wu-Chou et al. · 2021 · Clinical Cancer Research
Tumour‐induced immune suppression: role of inflammatory mediators released by myelomonocytic cells
Yumeng Mao, Isabel C. Poschke, Rolf W. Kiessling · 2014 · Journal of Internal Medicine
A Short Treatment with Galactomannan GM-CT-01 Corrects the Functions of Freshly Isolated Human Tumor–Infiltrating Lymphocytes
Nathalie Demotte, René Bigirimana, Grégoire Wieërs, Vincent Stroobant, Jean-Luc Squifflet, Javier Carrasco, Kris Thielemans, Jean‐François Baurain, Patrick Van Deŕ Smissen, Pierre J. Courtoy et al. · 2014 · Clinical Cancer Research
A short history of heme dioxygenases: rise, fall and rise again
Emma Lloyd Raven · 2016 · JBIC Journal of Biological Inorganic Chemistry
Immunotherapy in colorectal cancer: for the select few or all?
Sukeshi Patel Arora, Devalingam Mahalingam · 2018 · Journal of Gastrointestinal Oncology
Overexpression of Indoleamine 2,3-Dioxygenase 1 Promotes Epithelial-Mesenchymal Transition by Activation of the IL-6/STAT3/PD-L1 Pathway in Bladder Cancer
Wentao Zhang, Junfeng Zhang, Ziwei Zhang, Yadong Guo, Yuan Wu, Ruiliang Wang, Longsheng Wang, Shiyu Mao, Xudong Yao · 2018 · Translational Oncology
Salmonella-mediated therapy targeting indoleamine 2, 3-dioxygenase 1 (IDO) activates innate immunity and mitigates colorectal cancer growth
Thuy Xuan Phan, Vu H. Nguyen, Marcela d'Alincourt Salazar, Edwin Ramos Manuel, Teodora I. Kaltcheva, Weimin Tsai, Bruce R. Blazar, Don J. Diamond, Laleh Golkar Melstrom · 2019 · Cancer Gene Therapy
Tryptophan metabolism and indoleamine 2,3-dioxygenase expression in coeliac disease
Marı́a Isabel Torres, M A López-Casado, Pedro Lorite, Antonio Ríos · 2007 · Clinical & Experimental Immunology
The stress kinase GCN2 does not mediate suppression of antitumor T cell responses by tryptophan catabolism in experimental melanomas
Sonner, Jana K., Deumelandt, Katrin, Ott, Martina, Thomé, Carina M., Rauschenbach, Katharina J., Schulz, Sandra, Munteanu, Bogdan, Mohapatra, Soumya, Adam, Isabell, Hofer, Ann-Cathrin et al. · 2016 · OncoImmunology
Targeting the Immunoregulatory Indoleamine 2,3 Dioxygenase Pathway in Immunotherapy
Burles A Johnson rd, Babak Baban, Andrew L. Mellor · 2009 · Immunotherapy
The emerging role of viruses in the treatment of solid tumours
M.G. Bourke, S. Salwa, Kevin Joseph Harrington, Michael Jonathan Kucharczyk, Patrick F. Forde, M. de Kruijf, Declan M. Soden, Mark Tangney, John Kevin Collins, Gerald C. O’Sullivan · 2011 · Cancer Treatment Reviews
Recent advances and future of immunotherapy for glioblastoma
Neha Kamran, Anda‐Alexandra Calinescu, Marianela Candolfi, Mayuri Chandran, Yohei Mineharu, Antonela Sofía Asad, Carl Johannes Koschmann, Felipe Javier Núñez, Pedro Ricardo Lowenstein, Maria Graciela Castro · 2016 · Expert Opinion on Biological Therapy
Sculpting tumor microenvironment with immune system: from immunometabolism to immunoediting
Y-R Yu, Ping‐Chih Ho · 2019 · Clinical & Experimental Immunology
NAD-Biosynthetic and Consuming Enzymes as Central Players of Metabolic Regulation of Innate and Adaptive Immune Responses in Cancer
Valentina Audrito, Antonella Managò, Federica Gaudino, Leonardo Sorci, Vincenzo Gianluca Messana, Nadia Raffaelli, Silvia Deaglio · 2019 · Frontiers in Immunology
Regulatory T cells in solid tumor immunotherapy: effect, mechanism and clinical application
Yan Pan, Hanqiong Zhou, Zhenqiang Sun, Yichen Zhu, Zhe Zhang, Jing Han, Yang Liu, Qiming Wang · 2025 · Cell Death and Disease
Cytokine gene therapy for malignant glioma
Hideho Okada, Ian F. Pollack · 2004 · Expert Opinion on Biological Therapy
Inhibiting tryptophan metabolism enhances interferon therapy in kidney cancer
Josephine F. Trott, Jeffrey J. Kim, Omran Abu Aboud, Hiromi Inoue Wettersten, Benjamin J. Stewart, Grace E. Berryhill, Francisco Alejandro Uzal, Russell C. Hovey, Ching‐Hsien Chen, Katie Anderson et al. · 2016 · Oncotarget
Discovery of Novel Indoleamine 2,3-Dioxygenase 1 (IDO1) and Histone Deacetylase (HDAC) Dual Inhibitors
Kun Fang, Guoqiang Dong, Yu Li, Shipeng He, Ying Wu, Shanchao Wu, Wei Wang, Chunquan Sheng · 2018 · ACS Medicinal Chemistry Letters
Novel Approaches to Acute Myeloid Leukemia Immunotherapy
Ofrat Beyar‐Katz, Saar I. Gill · 2018 · Clinical Cancer Research
Role of IFNγ in Allograft Tolerance Mediated by CD4+CD25+ Regulatory T Cells by Induction of IDO in Endothelial Cells
Paméla Thébault, Thomas Condamine, M Heslan, Marcelo Hill, I Bernard, Abdelhadi Saoudi, Régis Josien, Ignacio Anegón, María Cristina Cuturi, Elise Chiffoleau · 2007 · American Journal of Transplantation
Effects of 1-methyltryptophan stereoisomers on IDO2 enzyme activity and IDO2-mediated arrest of human T cell proliferation
Feng Qian, Jianqun Liao, Jeannine Villella, Robert P. Edwards, Paweł Kaliński, Shashikant Lele, Protul A. Shrikant, Kunle O. Odunsi · 2012 · Cancer Immunology Immunotherapy
Production of an antigenic peptide by insulin-degrading enzyme
Nicolas Parmentier, Vincent Stroobant, Didier Colau, Philippe de Diesbach, Sandra Morel, Jacques Chapiro, Peter Van Endert, Benoit J. Van den Eynde · 2010 · Nature Immunology
Regional immunity in melanoma: immunosuppressive changes precede nodal metastasis
Aaron Scott Mansfield, Shernan G. Holtan, Travis Edward Grotz, Jake Allred, James W. Jakub, Lori A. Erickson, Svetomir N. Markovic · 2010 · Modern Pathology
Major Developments in the Design of Inhibitors along the Kynurenine Pathway
Kelly R. Jacobs, Gloria Castellano‐González, Gilles J. Guillemin, David B. Lovejoy · 2017 · Current Medicinal Chemistry